annual D&A:
$317.00K+$20.00K(+6.73%)Summary
- As of today (August 22, 2025), ELVN annual depreciation & amortization is $317.00 thousand, with the most recent change of +$20.00 thousand (+6.73%) on December 31, 2024.
- During the last 3 years, ELVN annual D&A has risen by +$202.00 thousand (+175.65%).
- ELVN annual D&A is now -47.17% below its all-time high of $600.00 thousand, reached on December 31, 2022.
Performance
ELVN Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$81.00K+$7000.00(+9.46%)Summary
- As of today (August 22, 2025), ELVN quarterly depreciation & amortization is $81.00 thousand, with the most recent change of +$7000.00 (+9.46%) on June 30, 2025.
- Over the past year, ELVN quarterly D&A has increased by +$3000.00 (+3.85%).
- ELVN quarterly D&A is now -81.96% below its all-time high of $449.00 thousand, reached on December 31, 2022.
Performance
ELVN quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$315.00K+$3000.00(+0.96%)Summary
- As of today (August 22, 2025), ELVN TTM depreciation & amortization is $315.00 thousand, with the most recent change of +$3000.00 (+0.96%) on June 30, 2025.
- Over the past year, ELVN TTM D&A has increased by +$2000.00 (+0.64%).
- ELVN TTM D&A is now -52.84% below its all-time high of $668.00 thousand, reached on September 30, 2023.
Performance
ELVN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ELVN Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | +3.9% | +0.6% |
| 3 y3 years | +175.7% | +55.8% | +125.0% |
| 5 y5 years | +860.6% | +224.0% | +542.9% |
ELVN Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -47.2% | +175.7% | -82.0% | +55.8% | -52.8% | +125.0% |
| 5 y | 5-year | -47.2% | +860.6% | -82.0% | +252.2% | -52.8% | +542.9% |
| alltime | all time | -47.2% | +860.6% | -82.0% | +252.2% | -52.8% | +1212.5% |
ELVN Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $81.00K(+9.5%) | $315.00K(+1.0%) |
| Mar 2025 | - | $74.00K(-7.5%) | $312.00K(-1.6%) |
| Dec 2024 | $317.00K(+6.7%) | $80.00K(0.0%) | $317.00K(+0.6%) |
| Sep 2024 | - | $80.00K(+2.6%) | $315.00K(+0.6%) |
| Jun 2024 | - | $78.00K(-1.3%) | $313.00K(+1.3%) |
| Mar 2024 | - | $79.00K(+1.3%) | $309.00K(+4.0%) |
| Dec 2023 | $297.00K(-50.5%) | $78.00K(0.0%) | $297.00K(-55.5%) |
| Sep 2023 | - | $78.00K(+5.4%) | $668.00K(+2.8%) |
| Jun 2023 | - | $74.00K(+10.4%) | $650.00K(+3.5%) |
| Mar 2023 | - | $67.00K(-85.1%) | $628.00K(+4.7%) |
| Dec 2022 | $600.00K | $449.00K(+648.3%) | $600.00K(+240.9%) |
| Sep 2022 | - | $60.00K(+15.4%) | $176.00K(+25.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $52.00K(+33.3%) | $140.00K(+23.9%) |
| Mar 2022 | - | $39.00K(+56.0%) | $113.00K(+14.1%) |
| Dec 2021 | $115.00K(+18.6%) | - | - |
| Dec 2021 | - | $25.00K(+4.2%) | $99.00K(+2.1%) |
| Sep 2021 | - | $24.00K(-4.0%) | $97.00K(-1.0%) |
| Jun 2021 | - | $25.00K(0.0%) | $98.00K(0.0%) |
| Mar 2021 | - | $25.00K(+8.7%) | $98.00K(+1.0%) |
| Dec 2020 | $97.00K(+193.9%) | $23.00K(-8.0%) | $97.00K(+31.1%) |
| Sep 2020 | - | $25.00K(0.0%) | $74.00K(+51.0%) |
| Jun 2020 | - | $25.00K(+4.2%) | $49.00K(+104.2%) |
| Mar 2020 | - | $24.00K | $24.00K |
| Dec 2019 | $33.00K | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual D&A year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Enliven Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM D&A year-on-year change?
What is Enliven Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of ELVN is $317.00K
What is the all time high annual D&A for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual depreciation & amortization is $600.00K
What is Enliven Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, ELVN annual depreciation & amortization has changed by +$20.00K (+6.73%)
What is Enliven Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of ELVN is $81.00K
What is the all time high quarterly D&A for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly depreciation & amortization is $449.00K
What is Enliven Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, ELVN quarterly depreciation & amortization has changed by +$3000.00 (+3.85%)
What is Enliven Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of ELVN is $315.00K
What is the all time high TTM D&A for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM depreciation & amortization is $668.00K
What is Enliven Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, ELVN TTM depreciation & amortization has changed by +$2000.00 (+0.64%)